Psyence Biomedical (PBM) Institutional Ownership $3.18 +0.72 (+29.27%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Psyence Biomedical (NASDAQ:PBM)CurrentInstitutional OwnershipPercentage77.44%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$6.57MNumber ofInstitutional Sellers(last 12 months)0 Get PBM Insider Trade Alerts Want to know when executives and insiders are buying or selling Psyence Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Psyence Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2024 AdvisorShares Investments LLC463,042$148K0.0%+70.7%5.269% 5/20/2024 Virtu Financial LLC26,419$30K0.0%N/A0.301% (Data available from 1/1/2016 forward) PBM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBM shares? During the previous two years, the following institutional investors and hedge funds held shares of Psyence Biomedical shares: AdvisorShares Investments LLC ($148K), Virtu Financial LLC ($30K).Learn more on PBM's institutional investors. What percentage of Psyence Biomedical stock is owned by institutional investors? 77.44% of Psyence Biomedical stock is owned by institutional investors. Learn more on PBM's institutional investor holdings. Which institutional investors have been buying Psyence Biomedical stock? The following institutional investors have purchased Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($191.71K), and Virtu Financial LLC ($26.42K). How much institutional buying is happening at Psyence Biomedical? Institutional investors have bought a total of 218,125 shares in the last 24 months. This purchase volume represents approximately $6.57M in transactions. Related Companies Edesa Biotech Major Shareholders Organovo Major Shareholders CNS Pharmaceuticals Major Shareholders Syros Pharmaceuticals Major Shareholders Hoth Therapeutics Major Shareholders GT Biopharma Major Shareholders Elevai Labs Major Shareholders IM Cannabis Major Shareholders Can-Fite BioPharma Major Shareholders Biomerica Major Shareholders This page (NASDAQ:PBM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
